Work

Human herpesvirus‐8‐related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin

Year: 2005

Type: article

Abstract: The iatrogenic form of Kaposi's sarcoma (KS) is typically observed among transplant recipients, and the most appropriate therapeutic approach (usually including reduction of immunosuppression, specific chemotherapy, and/or administration of antiviral agents against human herpes virus-8) is still controversial. Available experiences on the effect of the anti-herpes viruses drug cidofovir provide conflicting results. Herein, we report the clinical, histological, and virological features of a liver transplant recipient successfully treated with a combined therapy of cidofovir and liposomal daunorubicin, associated with a reduction of the immunosuppressive regimen, for an advanced cutaneous and visceral KS.

Source: Transplant Infectious Disease

DOI: 10.1111/j.1399-3062.2005.00081.x